Skip to main content
. Author manuscript; available in PMC: 2023 Aug 30.
Published in final edited form as: Int J Biol Macromol. 2020 May 25;160:26–34. doi: 10.1016/j.ijbiomac.2020.05.183

Figure 6.

Figure 6.

SJ-D-2 competes with heparin for FGF1 (A and B) binding with a IC50 of 100 nM and SJ-D-I competes with heparin for FGF2 (C and D) binding with an IC50 of 110 nM. Concentrations were 100 and 33 nM for FGF1 and FGF2, respectively. All bar graphs based on triplicate experiments. Std. dev. is shown.